RiaSTAP New Zealand - English - Medsafe (Medicines Safety Authority)

riastap

csl behring (nz) ltd - fibrinogen 900mg - 1300mg (human) - powder for injection - 1 g - active: fibrinogen 900mg - 1300mg (human) excipient: albumin arginine hydrochloride sodium chloride sodium citrate - treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenaemia and hypofibrinogenaemia.

VERASEAL SOLUTIONS FOR SEALANT 80 mgml 500 IUml Singapore - English - HSA (Health Sciences Authority)

veraseal solutions for sealant 80 mgml 500 iuml

grifols asia pacific pte. ltd. - human fibrinogen; human thrombin - solution - human fibrinogen 80 mg/ml; human thrombin 500 iu/ml

TISSEEL Ready to use Solutions for Sealant Ireland - English - HPRA (Health Products Regulatory Authority)

tisseel ready to use solutions for sealant

baxter healthcare limited - human fibrinogen; aprotinin; human factor xiii; human thrombin; calcium chloride - solution for sealant - . - local hemostatics; tissue adhesives

TISSEEL Ready to use Solutions for Sealant Ireland - English - HPRA (Health Products Regulatory Authority)

tisseel ready to use solutions for sealant

baxter holding b.v. - human fibrinogen; aprotinin; human factor xiii; human thrombin; calcium chloride - solution for sealant - . - local hemostatics; tissue adhesives

CSL New Zealand Haemocomplettan P, Human Fibrinogen, 1 g (50 mL) or 2 g (100mL), powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

csl new zealand haemocomplettan p, human fibrinogen, 1 g (50 ml) or 2 g (100ml), powder for injection vial

csl behring australia pty ltd - fibrinogen -

Fibclot 1,5 g inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fibclot 1,5 g inj./inf. sol. (pwdr. + solv.) i.v. vial

laboratoire français du fractionnement et des biotechnologies s.a. - human fibrinogen humain 1,5 g - powder and solvent for solution for injection/infusion - 1,5 g - human fibrinogen 1.5 g - fibrinogen, human

Fibryga 1 g inj./inf. sol. (pwdr. + solv.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fibryga 1 g inj./inf. sol. (pwdr. + solv.) i.v. vial

octapharma benelux sa-nv - human fibrinogen humain 1 g - powder and solvent for solution for injection/infusion - 1 g - human fibrinogen 1 g - fibrinogen, human

Riastap 1 g inj./inf. sol. (pwdr.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

riastap 1 g inj./inf. sol. (pwdr.) i.v. vial

csl behring gmbh - human fibrinogen humain 900 mg - 1300 mg - powder for solution for injection/infusion - 1 g - human fibrinogen - fibrinogen, human

Human Albumin 20% Biotest Low Salt Content Malta - English - Medicines Authority

human albumin 20% biotest low salt content

biotest pharma gmbh landsteinerstrasse 5, 63303 dreieich, germany - human plasma, protein - solution for infusion - human plasma protein 200 g/l - blood substitutes and perfusion solutions

Voncento European Union - English - EMA (European Medicines Agency)

voncento

csl behring gmbh - human coagulation factor viii, human von willebrand factor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand disease (vwd)prophylaxis and treatment of haemorrhage or surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated.haemophilia a (congenital factor-viii deficiency)prophylaxis and treatment of bleeding in patients with haemophilia a.